Favorable outcome in infants with AML after intensive first- and second-line treatment: an AML-BFM study group report

Infants

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Leukemia 2012-04, Vol.26 (4), p.654-661
Hauptverfasser:	Creutzig, U, Zimmermann, M, Bourquin, J-P, Dworzak, M N, Kremens, B, Lehrnbecher, T, von Neuhoff, C, Sander, A, von Stackelberg, A, Schmid, I, Starý, J, Steinbach, D, Vormoor, J, Reinhardt, D
Format:	Artikel
Sprache:	eng
Schlagworte:	Acute myeloid leukemia Age Anthracycline Anthracyclines - administration & dosage Biological and medical sciences Cancer Research Cancer therapies Care and treatment Child Child, Preschool Children Critical Care Medicine Cytarabine Cytarabine - administration & dosage Cytogenetics Female Hematologic and hematopoietic diseases Hematology Hematopoietic Stem Cell Transplantation Histone-Lysine N-Methyltransferase Humans Infant Infants Intensive Internal Medicine Leukemia Leukemia, Myeloid, Acute - genetics Leukemia, Myeloid, Acute - mortality Leukemia, Myeloid, Acute - therapy Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis Male Medical prognosis Medical research Medical sciences Medicine Medicine & Public Health Multivariate Analysis Myeloid-Lymphoid Leukemia Protein - genetics Oncology original-article Patients Pediatrics Remission Remission (Medicine) Salvage Therapy Stem cell transplantation Stem cells Survival Toxicity Transplantation Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!